Nicole Kelsey Joins AVITA Medical as Chief Legal and Compliance Officer

AVITA Medical Inc. has appointed Nicole Linda Kelsey as chief legal and compliance officer, and corporate secretary. Kelsey replaces Donna Shiroma, who is retiring after serving six years as general counsel, compliance officer, and corporate secretary.

“We are incredibly grateful to Donna for her expertise and leadership, which have been instrumental to the growth of AVITA Medical,” AVITA Medical CEO Jim Corbett said. “Donna’s commitment and contributions have left an indelible mark. We express our deepest appreciation and wish her all the best in retirement.”
 
Kelsey has more than two decades of executive legal experience with expertise in M&A, securities, and governance, as well as a strong track record building and leading global regulatory and compliance programs. Previously, she was chief legal officer and secretary for Amyris Inc. and general counsel and secretary at Criteo S.A. Prior to these roles, Kelsey was the principal legal counsel for Medtronic plc.

Kelsey earned her law degree from Northwestern Pritzker School of Law.
 
“Nicole is a proven executive with extensive experience developing global regulatory and compliance programs,” Corbett stated. “As we continue to scale and broaden our organizational capabilities, Nicole’s international expertise and strategic leadership will enhance our legal and compliance strategies and support our commercial growth initiatives.”
 
Shiroma will be assisting with the transition.

AVITA Medical is a commercial-stage regenerative medicine company developing devices for wound care management and skin restoration. At the forefront of its platform is the RECELL System, approved by the U.S. Food and Drug Administration for the treatment of thermal burn wounds and full-thickness skin defects, and for repigmentation of stable depigmented vitiligo lesions. RECELL harnesses the regenerative properties of a patient’s own skin to create Spray-On Skin Cells, delivering a transformative solution at the point-of-care. This technology serves as the catalyst for a new treatment paradigm enabling improved clinical outcomes. AVITA Medical also holds the exclusive rights to market, sell, and distribute PermeaDerm, a biosynthetic wound matrix, in the United States.
 
In international markets, the RECELL System is approved to promote skin healing in a wide range of applications including burns, full-thickness skin defects, and vitiligo. The RECELL System is TGA-registered in Australia, has received CE-mark approval in Europe and has PMDA approval in Japan.